Revenue
2017
2018
2019
2020
2021
2022
2024
2025
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.8M | $4.4M | $10.4M | $4.1M | $4.1M | $20,000 | $75,607 | $3.4M | $5.1M | $954,470 | $166,195 | $140,500 | $588,163 | $180,000 | $45,500 |
| Gross profit | $1.6M | $1.5M | $1.5M | $569,684 | $611,775 | $370,866 | $1.2M | $649,861 | $1.5M | $112,567 | $59,276 | $89,990 | $186,516 | $122,898 | $45,500 |
| Research & development | — | — | — | — | $110,338 | $107,351 | $290,542 | $197,119 | $502,209 | $814,014 | $1.3M | $1.1M | $980,170 | $1.1M | $662,347 |
| Operating expenses | $4.9M | $7.7M | $8.1M | $6.6M | $5.3M | $4.3M | $5.2M | $5.9M | $5.1M | $7.1M | $7.0M | $6.6M | $5.9M | $5.4M | $4.5M |
| Operating income | −$3.3M | −$6.2M | −$6.6M | −$6.0M | −$4.7M | −$3.9M | −$4.1M | −$5.3M | −$3.6M | −$7.0M | −$7.0M | −$6.5M | −$5.7M | −$5.2M | −$4.5M |
| EBITDAderived | — | −$6.1M | −$6.5M | −$6.0M | −$4.7M | −$3.9M | −$4.0M | −$5.2M | −$3.5M | −$6.9M | −$7.0M | −$6.5M | −$5.7M | −$5.2M | −$4.4M |
| Net income | −$18.3M | −$18.2M | −$10.8M | −$2.1M | $13.3M | −$27.5M | −$11.3M | −$5.2M | −$4.1M | −$11.6M | −$11.1M | −$8.8M | −$10.6M | −$5.6M | −$4.5M |
| Basic EPSper diluted share | — | -$0.01 | -$0.02 | -$0.02 | $0.64 | -$12.66 | -$50.93 | -$0.10 | -$0.03 | -$0.07 | -$0.15 | -$0.32 | -$0.92 | -$0.81 | -$0.80 |
| Diluted EPSper diluted share | — | -$0.01 | -$0.02 | -$0.02 | $0.04 | -$12.66 | — | -$0.10 | -$0.03 | -$0.07 | -$0.15 | -$0.32 | — | — | — |